中国执业药师
中國執業藥師
중국집업약사
CHINA LICENSED PHARMACIST
2014年
8期
10-14
,共5页
临床药师%工作模式%临床路径%慢性阻塞性肺疾病%戴明循环模式
臨床藥師%工作模式%臨床路徑%慢性阻塞性肺疾病%戴明循環模式
림상약사%공작모식%림상로경%만성조새성폐질병%대명순배모식
Clinical Pharmacist%Working Mode%Clinical Pathway%Chronic Obstructive Pulmonary Disease%PDCA
目的：对临床药师参与慢性阻塞性肺疾病（COPD）临床路径的过程进行分析，讨论临床药师在实施临床路径中的工作模式及作用。方法：将纳入COPD临床路径的患者分为治疗组和对照组，临床药师通过戴明循环（PDCA）模式参与管理治疗组患者的药物治疗，经过2个PDCA循环后，对比分析2个循环组及治疗组和对照组病例平均住院日、平均住院费、药物治疗费、药品不良反应（ADR）发生率、患者药物治疗依从性、满意度有无统计学意义。结果：2个PDCA循环组之间药物治疗费差异有统计学意义（P＜0.05）；平均住院日、平均住院费、ADR发生率、药物治疗依从性、满意度差异无统计学意义（P＞0.05）；治疗组与对照组比较除平均住院日、平均住院费差异无统计学意义外，药物治疗费、ADR发生率、药物治疗依从性、满意度差异均有统计学意义（P＜0.05）。结论：临床药师通过PDCA的管理模式参与临床路径的实施，能够有效促进药物治疗的规范使用、加强患者的药物治疗监护，ADR得到及时处置和上报，患者药物治疗依从性和满意度得到提高。
目的：對臨床藥師參與慢性阻塞性肺疾病（COPD）臨床路徑的過程進行分析，討論臨床藥師在實施臨床路徑中的工作模式及作用。方法：將納入COPD臨床路徑的患者分為治療組和對照組，臨床藥師通過戴明循環（PDCA）模式參與管理治療組患者的藥物治療，經過2箇PDCA循環後，對比分析2箇循環組及治療組和對照組病例平均住院日、平均住院費、藥物治療費、藥品不良反應（ADR）髮生率、患者藥物治療依從性、滿意度有無統計學意義。結果：2箇PDCA循環組之間藥物治療費差異有統計學意義（P＜0.05）；平均住院日、平均住院費、ADR髮生率、藥物治療依從性、滿意度差異無統計學意義（P＞0.05）；治療組與對照組比較除平均住院日、平均住院費差異無統計學意義外，藥物治療費、ADR髮生率、藥物治療依從性、滿意度差異均有統計學意義（P＜0.05）。結論：臨床藥師通過PDCA的管理模式參與臨床路徑的實施，能夠有效促進藥物治療的規範使用、加彊患者的藥物治療鑑護，ADR得到及時處置和上報，患者藥物治療依從性和滿意度得到提高。
목적：대림상약사삼여만성조새성폐질병（COPD）림상로경적과정진행분석，토론림상약사재실시림상로경중적공작모식급작용。방법：장납입COPD림상로경적환자분위치료조화대조조，림상약사통과대명순배（PDCA）모식삼여관리치료조환자적약물치료，경과2개PDCA순배후，대비분석2개순배조급치료조화대조조병례평균주원일、평균주원비、약물치료비、약품불량반응（ADR）발생솔、환자약물치료의종성、만의도유무통계학의의。결과：2개PDCA순배조지간약물치료비차이유통계학의의（P＜0.05）；평균주원일、평균주원비、ADR발생솔、약물치료의종성、만의도차이무통계학의의（P＞0.05）；치료조여대조조비교제평균주원일、평균주원비차이무통계학의의외，약물치료비、ADR발생솔、약물치료의종성、만의도차이균유통계학의의（P＜0.05）。결론：림상약사통과PDCA적관리모식삼여림상로경적실시，능구유효촉진약물치료적규범사용、가강환자적약물치료감호，ADR득도급시처치화상보，환자약물치료의종성화만의도득도제고。
Objective:To evaluate and discuss the work mode and role of clinical pharmacist in participation in the implementation of clinical pathway of chronic obstructive pulmonary disease(COPD).Methods:The patients with COPD in the clinical pathway were divided into treatment group and control group. The clinical pharmacists participated in the management of medication of the patients in treatment group through PDCA mode. After two cycles of PDCA,the comparative analysis of statistical significance was made among the two circulation groups and treatment and control groups in the aspects of the average length and expense of hospitalization,medication cost,ADR incidence,drug therapy adherence and the degree of satisfaction.Results:The difference of medication cost between the two PDCA cycle groups had statistical significance(P<0.05)but the average length and expense of hospitalization,ADR incidence,the drug therapy adherence and the degree of satisfaction had no statistical significance(P>0.05). Compared with the control group,other than the average length and cost of hospitalization which had no significance in treatment group,the medication cost,ADR incidence,drug therapy adherence and degree of satisfaction all had statistical significance(P>0.05).Conclusion:By means of PDCA management mode,the participation of clinical pharmacists in the implementation of clinical pathway can effectively promote the standardized medication,strengthen the medication care of patients,and make a timely disposal and report of ADRs. The patient medication compliance and the degree of satisfaction were improved.
